Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
Fierce Pharma
JNJ
schizophrenia
generics
Trinza
Viatris
Flag link:
Drug Shortages Near an All-Time High, Leading to Rationing
Drug Shortages Near an All-Time High, Leading to Rationing
NY Times, NY
drug shortages
cancer
generics
Flag link:
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Novartis
Sandoz
biosimilars
generics
women executives
Flag link:
SCOTUS Kills Hope for Eligibility Certainty and Nixes Teva’s ‘Skinny Label’ Appeal
SCOTUS Kills Hope for Eligibility Certainty and Nixes Teva’s ‘Skinny Label’ Appeal
IP Watchdog
Teva Pharmaceutical
Supreme Court
generics
legal
skinny labels
Flag link:
Senate health committee seeks to rein in drug prices with four new bills
Senate health committee seeks to rein in drug prices with four new bills
BioSpace
Senate
drug pricing
generics
PBMs
legislation
Flag link:
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Fierce Pharma
Novartis
Sandoz
generics
Adalvo
Flag link:
12,000 diseases lack treatments. One doctor thinks generics could yield cures
12,000 diseases lack treatments. One doctor thinks generics could yield cures
Stat
orphan diseases
generics
artificial intelligence
Flag link:
Sanders, Cassidy reach deal to increase access to generic prescription drugs, reform PBMs
Sanders, Cassidy reach deal to increase access to generic prescription drugs, reform PBMs
Fierce Healthcare
legislation
PBMs
generics
Senate
Flag link:
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Fierce Pharma
Amgen
Otezla
immunology
generics
Sandoz
Zydus
patents
Flag link:
Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys
Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys
Fierce Pharma
Takeda
pay-for-delay
generics
gout
Colcrys
Flag link:
Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design
Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design
Drug Channels
drug pricing
generics
PBMs
Flag link:
Biogen gets EU court ruling in favor of blocking Tecfidera generic entry
Biogen gets EU court ruling in favor of blocking Tecfidera generic entry
Seeking Alpha
Biogen
EMA
Europe
MS
multiple sclerosis
Tecfidera
generics
Flag link:
Jazz loses appeal, will have patent delisted from the Orange Book
Jazz loses appeal, will have patent delisted from the Orange Book
Endpoints
Jazz Pharma
Orange Book
narcolepsy
generics
legal
Flag link:
Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
Endpoints
generics
Dr Reddy's
Mayne Pharma
Flag link:
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Amarin
Hikma
legal
antitrust
generics
Vascepa
Flag link:
Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
Endpoints
Sun Pharma
generics
product recalls
Diltiazem
hypertension
Flag link:
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Sandoz
Novartis
Astellas
antifungals
Mycamine
generics
Flag link:
Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent
Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent
Endpoints
Novartis
Supreme Court
Gilenya
patents
generics
multiple sclerosis
MS
Flag link:
Jazz sues generics makers for infringement on cannabis-derived epilepsy drug
Jazz sues generics makers for infringement on cannabis-derived epilepsy drug
Fierce Pharma
Jazz Pharma
legal
cannabindoids
Epidiolex
generics
patents
Flag link:
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Reuters
Novartis
generics
antitrust
legal
Exforge
hypertension
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »